Breadcrumb
- Home
- Publications
- Proceedings
- Metabolic Engineering 11
- Poster Session
- Rapid Fire Poster Session 3
- 3-Amino-4-Hydroxy Benzoic Acid Production Via 3,4-AcAHBA in Escherichia coli
However, there are two problems with biological production of 3,4-AHBA in E. coli. The first problem is its rapid conversion to other chemical compounds. 3,4-AHBA is non-enzymatically converted to 2-aminophenoxazin-3-one-8-carboxylic acid (APOC) under aerobic/anaerobic condition, while enzymatically, it is converted to 3-acetylamino-4-hydroxybenzoic acid (3,4-AcAHBA). Approximately 39% of the exogenously added initial amount of 3,4-AHBA is converted into 3,4-AcAHBA in the presence of E. coli cells. The second problem is an inhibitory effect of 3,4-AHBA on the growth of E. coli cells. Addition of 60 mM exogenous 3,4-AHBA led to significant growth retardation of MG1655 cells.
In contrast to the instability of 3,4-AHBA in culture medium, exogenously added 3,4-AcAHBA maintains a constant concentration in culture medium during aerobic/anaerobic cultivation conditions. Furthermore, 3,4-AcAHBA is non-toxic for E. coli cells. Taking these observations into account, biotechnological production of 3,4-AcAHBA and its chemical deacetylation were considered to be feasible processes.
In S. griseus, N-acetyltransferase (NAT) encoded by natA is solely responsible for the N-acetylation of 3,4-AHBA. Homology analysis showed that an S. griseus NAT-like protein, NhoA, is conserved in E. coli. NhoA functions as an arylamine acetyltransferase that catalyzes the acetyl-CoA dependent N-acetylation of a variety of arylamine substrates. Our study demonstrated that the disruption of nhoA led to a loss of function and consequently the loss of 3,4-AcAHBA production, thus indicating that NhoA is solely responsible for the N-acetylation of 3,4-AHBA in E. coli.
For the synthesis of 3,4-AHBA, NspI and NspH from Streptomyces murayamaensis (the GriIH homologs) were expressed in E. coli. The E. coli MG1655 strain harboring the nspIH operon expression plasmid produced around 2.7 %(mol/mol) of 3,4-AHBA from glucose and by-produced AHBA derivatives. By combining genetic modification to improve ASA supply in the host strain and expression of nspI, nspH and nhoA, 3,4-AcAHBA production increased up to 13.3 %(mol/mol) without any by-production of AHBA derivative compounds. These results suggest a technological advantage of 3,4-AcAHBA fermentation.